Selvita pursues foreign expansion

WSE-listed biotechnology firm Selvita has established a subsidiary, Selvita Ltd.,  in Cambridge, UK, a press release read. It is the company's second branch based abroad. The first was founded in Boston, US early March. "The UK is a huge market. ... We think that our presence here will let us significantly increase exposure to small and medium biotechnology enterprises as well as British-born giants such as AstraZeneca, GlaxoSmithKline or Pfizer," Miłosz Gruca, the CEO of Selvita Ltd. said. The new subsidiary will be responsible for attracting partners to implement research and development projects, the release also informed.